Industrial AI solution

Pharma Supply Chain AI Cold-Chain & Shortage Resilience

Protect cold-chain integrity, predict shortages and analyse serialization data across your pharma supply network.

Plan the use case Explore ROI tools

Acceptance before scale

Baseline, representative test set, failure conditions and a named human owner are defined before production approval.

Direct answer

NeoBram helps industrial teams evaluate and build pharma supply chain ai for a defined workflow. The engagement starts with the operating decision, representative data, integration boundary, human owner and acceptance test. Deployment can be designed for offline, on-premises, edge or private-cloud operation when the selected components and licences support it.

Private deployment available

Why evaluate it

A Single Excursion Can Destroy a Batch.

The decision is whether this capability improves a defined workflow safely not whether an AI demo looks impressive.

Cold-chain pharma supply chains are unforgiving: a few hours outside temperature range can scrap millions of dollars of vaccines or biologics. Shortages create regulatory risk and patient harm.

AI gives supply chain leaders forward visibility: which shipments are at risk, which SKUs will go short, which lanes consistently underperform, and which suppliers are slipping on quality.

We deploy supply chain AI on top of SAP, Veeva, your serialization repository and IoT temperature data - with the data sovereignty and validation rigor pharma demands.

Candidate capabilities

What a production solution may need to do.

Each capability is validated against representative data and the customer's workflow. Product or model names describe possible components, not partnerships, certifications or guaranteed compatibility.

Cold-chain integrity AI

Real-time monitoring and predictive alerts on temperature, humidity and shock excursions across air, road and warehouse legs.

Per-shipment risk score during transit
Predictive excursion warning hours ahead
Auto-quarantine triggers on confirmed excursion
Carrier and lane performance benchmarking

Shortage prediction

A candidate capability to test against a documented baseline, representative scenarios and agreed human-review workflow.

SKU-by-market shortage probability
Root-cause decomposition per risk
Recommended mitigations (alt source, re-prioritise, allocate)
Auto-notification to commercial and regulatory teams

Serialization & traceability analytics

Turns DSCSA / EU FMD / GS1 serialization data into insight: diversion, counterfeiting, channel imbalance and verification anomalies.

Diversion and grey-market pattern detection
Verification anomaly clustering
Channel-level inventory visibility
Recall scope estimation via batch genealogy

Validated, audit-ready deployment

Full GxP validation pack, immutable audit trail and Part 11 e-signatures on every quality-relevant action.

ALCOA+ data integrity
IQ/OQ/PQ delivered with deployment
Locked model versions, change-controlled
Inspector read-only access mode

Architecture context

Select components after the boundary and test are clear.

The list is a design vocabulary. Final selection depends on licences, data location, latency, security, existing systems and customer approval.

Data sources

SAP / Oracle ERP
Orders & inventory
Veeva Vault
Quality & GxP docs
Serialization repository
DSCSA / EU FMD / GS1
IoT loggers (Sensitech, Berlinger)
Temp / humidity

AI & analytics

LSTM / Transformer
Shortage prediction
Anomaly detection
Cold-chain excursions
Graph analytics
Batch genealogy & traceability

Integration

EDI / API connectors
3PL data
TMS / WMS
Logistics
Regulatory reporting
DSCSA, EU FMD

Compliance

21 CFR Part 11
Audit trail & e-sig
GxP validation pack
IQ/OQ/PQ
Data integrity (ALCOA+)
Tamper-evident

Planning ranges

A standard path from decision to operation.

Discovery and qualification

1-2 weeks

Named workflow, owner, baseline, risks and go/no-go questions.

Readiness assessment

2-4 weeks

Data, integration, security, value and operating-readiness findings.

Technical proof of value

4-6 weeks

A bounded test on representative data with documented limitations.

Production pilot

8-12 weeks

One controlled workflow, integrated and evaluated with real users.

Enterprise or multi-site rollout

3-6+ months

Phased scale-out, monitoring, support and change management.

AI capability or CoE programme

3-6+ months

Governance, delivery methods, reusable assets and team enablement.

These are planning ranges, not guarantees. Readiness, validation, hardware, integration, access and change management affect the schedule.

Production safeguards

Private deployment is one control, not the whole control system.

Data boundary

Select offline, edge, on-premises or private-cloud deployment from the real operating constraints.
Document data flows, storage, deletion, backups and support access before production.
The customer approves every interface and any permitted external connection.

Model and application controls

Evaluate representative cases, uncertainty and harmful failure modes before use.
Use suitable access control, input handling and output guardrails for the selected risk.
Treat grounding and citations as testable behaviours, not as a promise of perfect answers.

Traceability and operation

Define identity, roles, logs, monitoring, updates, backup and incident handling.
Keep the evidence needed to investigate outputs and reproduce important decisions.
Assign a named business and technical owner for production operation.

Human authority

Domain, quality, safety and regulatory owners retain decision authority.
Compliance depends on the implemented system and the customer's validated controls.
Escalation and safe fallback are part of the acceptance criteria.

Limitations to plan for

Performance can change with data quality, equipment, process, product mix, documents, users or operating conditions. Third-party model and software licences still apply. AI output does not replace the responsible engineer, operator, quality owner, safety professional, legal adviser or regulator.

Buyer questions

Direct answers before you plan a pilot.

How accurate is cold-chain excursion prediction?+

This legacy draft included a quantitative benchmark that has not been published with a reviewable source or customer evidence. NeoBram now treats it as an open validation question and defines the baseline, test method, acceptance threshold and limitations during discovery.

Which serialization standards do you support?+

DSCSA (US), EU FMD, China NMPA, Russia Chestny Znak, Saudi SFDA, Korea KPIS. We work with serialization repositories like TraceLink, Adents, Movilitas and SAP ATTP, plus native GS1 EPCIS feeds.

How does shortage prediction work without complete supplier data?+

Does this stay GxP compliant?+

Yes. The platform is treated as a computerised system, validated and change-controlled. Models are locked at validated versions; updates require formal change control. Audit trail is immutable and Part 11 compliant. Validation pack delivered with deployment.

Can it integrate with SAP and Veeva?+

Yes. Native connectors for SAP S/4HANA and ECC (orders, inventory, batch master), Veeva Vault QMS / RIM, and major 3PL EDI feeds. Inserted into your existing process - no parallel tool to maintain.

What ROI is typical?+

There is no responsible universal ROI figure. Build the case from the selected workflow's baseline, error or downtime exposure, detectable opportunity, adoption, false-alert cost and full operating cost. NeoBram's calculators are illustrative planning tools; replace every assumption with customer evidence before an investment decision.

Bring one workflow

Define the evidence, boundary and acceptance test together.

Your team supplies process authority. NeoBram supplies AI architecture, engineering, evaluation and operating handover.

Plan the first project